145878-31-5
145878-31-5
Chemical Structure
L 368935
- CAS No.: 145878-31-5
- Formula:C27H26N8O2
- Molecular Weight:494.55
IUPAC Name: (R)-1-(3-(1H-tetrazol-5-yl)phenyl)-3-(1-isobutyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea
InChIKey: WOEBZQREQISGPC-VWLOTQADSA-N
SMILES: CC(C)CN1C2=CC=CC=C2C(C3=CC=CC=C3)=N[C@H](C1=O)NC(NC4=CC(C5=NN=NN5)=CC=C4)=O
Biological Activity: L 368935 is a cholecystokinin B receptor (CCKB receptor) antagonist. L 368935 is a brain-penetrant and centrally active compound[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L 368935 | L 368935 is a cholecystokinin B receptor (CCKB receptor) antagonist. L 368935 is a brain-penetrant and centrally active compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists [Content Brief]
- [2]. Patel S, et al. Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding. Eur J Pharmacol. 1994 Mar 3;253(3):237-44. [Content Brief]
